NBIX

Neurocrine Biosciences Stock Analysis

AI Rating

Good
  • Quality9/10
  • Growth↑ 8/10
  • Value↓ 3/10
Neurocrine Biosciences sales and earnings growth
NBIX Growth
Good
  • Revenue Y/Y↑ 27.75%
  • EPS Y/Y↑ 121.45%
  • FCF Y/Y↑ 68.89%
Neurocrine Biosciences gross and profit margin trends
NBIX Profitability
Great
  • Gross margin ↑ 98.20%
  • EPS margin↑ 21.60%
  • ROIC 5Y↑ 16.88%
Neurocrine Biosciences net debt vs free cash flow
NBIX Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.2
  • Interest coverage↓ NA

Neurocrine Biosciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Drug Manufacturers - Specialty & Generic stocks